Available studies (145 found)
| Short citation | Full citation | Bioassay | Epidemiology | Epi. meta-analysis | In vitro | Ecology |
|---|---|---|---|---|---|---|
| Mollenhauer 2011 | Mollenhauer MA, Bradshaw SG, Fair PA, McGuinn WD, and Peden-Adams MM. 2011. Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice. J Environ Sci Health A Tox Hazard Subst Environ Eng 46(2): 97-108. PubMed DOI | |||||
| Nakagawa 2012 | Nakagawa T, Ramdhan DH, Tanaka N, Naito H, Tamada H, Ito Y, Li Y, Hayashi Y, Yamagishi N, Yanagiba Y, Aoyama T, Gonzalez FJ, and Nakajima T. 2012. Modulation of ammonium perfluorooctanoate-induced hepatic damage by genetically different PPARalpha in mice. Arch Toxicol 86(1): 63-74. PubMed DOI | |||||
| Oh 2013 | Oh JH, Moon HB, and Choe ES. 2013. Alterations in differentially expressed genes after repeated exposure to perfluorooctanoate and perfluorooctanesulfonate in liver of Oryzias latipes. Arch Environ Contam Toxicol 64(3): 475-483. PubMed DOI | |||||
| Okada 2012 | Okada E, Sasaki S, Saijo Y, Washino N, Miyashita C, Kobayashi S, Konishi K, Ito YM, Ito R, Nakata A, Iwasaki Y, Saito K, Nakazawa H, and Kishi R. 2012. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants. Environ Res 112: 118-125. PubMed DOI | |||||
| Okada 2014 | Okada E, Sasaki S, Kashino I, Matsuura H, Miyashita C, Kobayashi S, Itoh K, Ikeno T, Tamakoshi A, and Kishi R. 2014. Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood. Environ Int 65: 127-134. PubMed DOI | |||||
| Osuna 2014 | Osuna CE, Grandjean P, Weihe P, and El-Fawal HA. 2014. Autoantibodies Associated with Prenatal and Childhood Exposure to Environmental Chemicals in Faroese Children. Toxicol Sci. PubMed DOI | |||||
| Peden-Adams 2008 | Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, and Keil DE. 2008. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 104(1): 144-154. PubMed DOI | |||||
| Peden-Adams 2009 | Peden-Adams MM, Stuckey JE, Gaworecki KM, Berger-Ritchie J, Bryant K, Jodice PG, Scott TR, Ferrario JB, Guan B, Vigo C, Boone JS, McGuinn WD, DeWitt JC, and Keil DE. 2009. Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS). Reprod Toxicol 27(3-4): 307-318. PubMed DOI | |||||
| Pennings 2015 | Pennings JL et al. Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood. J Immunotoxicol 2015; ():1-8. PubMed | |||||
| Predieri 2015 | Predieri B et al. High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes. Int J Endocrinol 2015; 2015 ():234358. PubMed DOI | |||||
| Qazi 2009a | Qazi MR, Bogdanska J, Butenhoff JL, Nelson BD, DePierre JW, and Abedi-Valugerdi M. 2009. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262(3): 207-214. PubMed DOI | |||||
| Qazi 2009b | Qazi MR, Xia Z, Bogdanska J, Chang SC, Ehresman DJ, Butenhoff JL, Nelson BD, DePierre JW, and Abedi-Valugerdi M. 2009. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). Toxicology 260(1-3): 68-76. PubMed DOI | |||||
| Qazi 2010a | Qazi MR, Abedi MR, Nelson BD, DePierre JW, and Abedi-Valugerdi M. 2010. Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. Int Immunopharmacol 10(11): 1420-1427. PubMed DOI | |||||
| Qazi 2010b | Qazi MR, Nelson BD, Depierre JW, and Abedi-Valugerdi M. 2010. 28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity? Toxicology 267(1-3): 132-139. PubMed DOI | |||||
| Qazi 2012 | Qazi MR, Nelson BD, DePierre JW, and Abedi-Valugerdi M. 2012. High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells in the bone marrow and these effects are partially dependent on reduced food consumption. Food Chem Toxicol 50(9): 2955-2963. PubMed DOI | |||||
| Qazi 2013a | Qazi MR, Hassan M, Nelson BD, Depierre JW, and Abedi-Valugerdi M. 2013. Sub-acute, moderate-dose, but not short-term, low-dose dietary pre-exposure of mice to perfluorooctanoate aggravates concanavalin A-induced hepatitis. Toxicol Lett 219(1): 1-7. PubMed DOI | |||||
| Qazi 2013b | Qazi MR, Hassan M, Nelson BD, DePierre JW, and Abedi-Valugerdi M. 2013. Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis. Toxicol Lett 217(1): 67-74. PubMed DOI | |||||
| Rosen 2007 | Rosen MB, Thibodeaux JR, Wood CR, Zehr RD, Schmid JE, and Lau C. 2007. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. Toxicology 239(1-2): 15-33. PubMed | |||||
| Rosen 2008a | Rosen MB, Abbott BD, Wolf DC, Corton JC, Wood CR, Schmid JE, Das KP, Zehr RD, Blair ET, and Lau C. 2008. Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid. Toxicol Pathol 36(4): 592-607. PubMed DOI | |||||
| Rosen 2008b | Rosen MB, Lee JS, Ren H, Vallanat B, Liu J, Waalkes MP, Abbott BD, Lau C, and Corton JC. 2008. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: Evidence for the involvement of nuclear receptors PPAR(alpha) and CAR. Toxicol Sci 103(1): 46-56. PubMed DOI | |||||
| Rosen 2010 | Rosen MB, Schmid JR, Corton JC, Zehr RD, Das KP, Abbott BD, and Lau C. 2010. Gene Expression Profiling in Wild-Type and PPARalpha-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARalpha-Independent Effects. PPAR Res 2010. PubMed DOI | |||||
| Ryu, 2014 | Ryu MH, Jha A, Ojo OO, Mahood TH, Basu S, Detillieux KA, Nikoobakht N, Wong CS, Loewen M, Becker AB, and Halayko AJ. 2014. Chronic exposure to perfluorinated compounds: impact on airway hyperresponsiveness and inflammation. Am J Physiol Lung Cell Mol Physiol. PubMed DOI | |||||
| Seacat 2002 | Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, and Butenhoff JL. 2002. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 68(1): 249-264. PubMed | |||||
| Seacat 2003 | Seacat AM, Thomford PJ, Hansen KJ, Clemen LA, Eldridge SR, Elcombe CR, and Butenhoff JL. 2003. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 183(1-3): 117-131. PubMed | |||||
| Singh 2012 | Singh TS, Lee S, Kim HH, Choi JK, and Kim SH. 2012. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators. Toxicol Lett 210(1): 64-70. PubMed DOI |
Showing studies 76-100 of 145